Skip to content

Psycho-Oncology & Quality of Life ​

Note: This page is educational. Fast-moving claims should be checked against current guidelines and primary literature. It does not replace medical or psychological advice.

TL;DR ​

Psycho-oncology is the multidisciplinary field that addresses the psychological, social, and behavioral dimensions of cancer — for patients, families, and clinicians. Roughly 30–40 % of cancer patients experience clinically significant distress at some point. Modern oncology guidelines treat distress screening as a 6th vital sign, alongside symptom management. Effective interventions exist (CBT, mindfulness, group support, pharmacotherapy, exercise, palliative integration) but access — especially in Brazil — remains uneven.


1. Why psycho-oncology matters ​

Cancer is a stressor unlike most others — life-threatening, prolonged, with treatments that themselves impose physical and psychological burden. Specific challenges:

  • Existential distress — diagnosis as a confrontation with mortality.
  • Treatment burden — surgery, chemo, radiation, immunotherapy fatigue and side effects.
  • Body image and identity — mastectomy, ostomy, alopecia, sexual function changes.
  • Caregiver and family strain — caregiving morbidity is real and measurable.
  • Pediatric and young-adult specifics — interrupted development, education, fertility.
  • Survivorship — fear of recurrence, post-treatment uncertainty, return to work.
  • End-of-life — dignity, decision-making, advance directives, palliative integration.
  • Healthcare team distress — moral injury, burnout in oncology professionals.

Distress is not weakness; it is a predictable response to a hard situation. Treating it improves quality of life and, in many studies, adherence and outcomes.


2. Common conditions ​

ConditionNotes
Adjustment disorderMost common — reaction to diagnosis or treatment
Major depressive disorder~15–25 % prevalence in cancer; underdiagnosed
Generalized anxiety, panicProcedural anxiety, fear of recurrence common
Post-traumatic stress (PTSD)Diagnosis or treatment as traumatic event; ~10–20 % at some point
Demoralization syndromeLoss of meaning, hopelessness without full depression
DeliriumEspecially advanced disease, opioids, metabolic causes
Sleep disorders, insomniaVery common; underestimated
Sexual dysfunctionVery common, rarely addressed proactively
Cognitive changes ("chemo brain")Subjective and objective domains; under-researched
Bereavement (caregivers)Anticipatory and post-loss; complicated grief

3. Distress screening — the "6th vital sign" ​

The NCCN Distress Thermometer (0–10 visual analog plus problem checklist) and the PHQ-9, GAD-7, and HADS are widely used in cancer settings. Screening should:

  • Happen at diagnosis, transitions of care, and survivorship.
  • Trigger a clear referral pathway when above threshold.
  • Be paired with cultural, language, and literacy adaptation.
  • Be more than checkbox compliance — actual response matters.

In Brazil, NCCN-translated screening tools are available; uptake varies by service.


4. Interventions that work ​

Evidence base summarized from systematic reviews: Sources: [1], [2]

Psychological / behavioral ​

  • Cognitive Behavioral Therapy (CBT) — depression, anxiety, insomnia, fear of recurrence; strongest evidence base.
  • Mindfulness-Based Stress Reduction (MBSR) — distress, fatigue, sleep.
  • Acceptance and Commitment Therapy (ACT) — meaning, values, distress.
  • Meaning-Centered Psychotherapy — advanced disease, demoralization.
  • Couples and family therapy — communication, caregiving, intimacy.
  • Group support — connection, normalization, shared coping.
  • Psychoeducation — informed coping, side-effect anticipation.

Lifestyle and behavioral ​

  • Aerobic and resistance exercise — fatigue (best evidence), depression, QoL. Sources: [2]
  • Yoga, tai chi — fatigue, sleep, mood.
  • Sleep hygiene + CBT-I for insomnia.
  • Nutrition and weight management — survivorship outcomes.

Pharmacotherapy ​

  • SSRIs / SNRIs — depression, anxiety; consider drug interactions (tamoxifen + paroxetine, etc.).
  • Mirtazapine — depression with anorexia / insomnia.
  • Methylphenidate — fatigue, cognitive symptoms (mixed evidence).
  • Benzodiazepines — short-term anxiety, procedural; not first-line for chronic anxiety.
  • Atypical antipsychotics — delirium.
  • Dexamethasone — fatigue near end-of-life (short-term). Sources: [2]

Telehealth and remote support ​

  • Telephone interventions show benefit for depression, anxiety, and emotional distress, with reasonable certainty. Sources: [1]
  • Web-based CBT and app-delivered support — growing evidence base, especially for younger patients.

5. Specific scenarios ​

Newly diagnosed ​

  • High distress; information overload; decision-making support.
  • Brief psycho-education + accessible team contact often sufficient.

Active treatment ​

  • Symptom management (fatigue, nausea, pain), social support, treatment adherence.
  • Procedural anxiety (chemo, scans) responds well to brief CBT and pharmacological support.

Advanced disease and palliative care ​

  • Goal-of-care conversations, advance directives.
  • Existential distress and demoralization respond to meaning-centered approaches.
  • Integrated palliative care (early — at diagnosis of advanced disease, not "end of options") improves QoL and survival in some trials.

Survivorship ​

  • Fear of recurrence is the most common ongoing concern; cognitive symptoms, fatigue, sexual function under-addressed.
  • Survivorship care plans (treatment summary + follow-up plan + late-effect surveillance) are evolving standard of care.

Pediatric ​

  • Family-centered; school re-integration; developmental considerations.
  • See Pediatric oncology.

Caregivers and bereavement ​

  • High morbidity in caregivers; psychological support during AND after.
  • Complicated grief affects ~10–20 %; specific therapies exist.

6. Brazilian context ​

  • Sociedade Brasileira de Psico-Oncologia (SBPO) organizes the field; certification and training pathways exist.
  • Psycho-oncology services are concentrated in tertiary centers (A.C. Camargo, INCA, GRAACC, Hospital Sírio-Libanês, Albert Einstein, ICESP, Hospital de Câncer de Barretos, Hospital Pequeno Príncipe, etc.).
  • SUS coverage of psychological care for oncology patients is uneven; community-based programs and partnerships with universities help fill gaps.
  • Religious and spiritual support plays a culturally significant role in Brazilian patient coping; integration into psycho-oncological services is expanding.
  • Telehealth psycho-oncology grew significantly post-2020 and remains a major access lever for patients outside major capitals.

7. What technology can contribute ​

  • Distress screening at scale — embedded in EHR/portal workflows with thresholded referrals.
  • ePROs and remote monitoring — early detection of deteriorating symptoms (depression, pain, fatigue).
  • CBT/MBSR content delivery — apps and web-based programs validated for cancer populations.
  • Caregiver tools — coordination, respite scheduling, peer support.
  • Survivorship-care-plan generators — auto-populated from treatment data.
  • Conversational AI — well-designed it can complement (not replace) human support; poorly designed it reinforces avoidance.
  • Equity — language, literacy, and accessibility considerations central, not afterthought.

See also ​


References ​

  1. Ream E, Hughes AE, Cox A, et al. Telephone interventions for symptom management in adults with cancer. Cochrane Database Syst Rev 2020;6:CD007568. PMID 32483832. https://doi.org/10.1002/14651858.CD007568.pub2
  2. Stone P, Candelmi DE, Kandola K, et al. Management of Fatigue in Patients with Advanced Cancer. Curr Treat Options Oncol 2023;24:93-107. PMID 36656503. https://doi.org/10.1007/s11864-022-01045-0
  3. U.S. National Cancer Institute. Coping with cancer. https://www.cancer.gov/about-cancer/coping
  4. American Cancer Society. Coping with cancer. https://www.cancer.org/cancer.html
  5. Cleveland Clinic. Cancer (overview). https://my.clevelandclinic.org/health/diseases/12194-cancer
  6. Sociedade Brasileira de Psico-Oncologia (SBPO). https://www.sbpo.org.br/
  7. A.C. Camargo Cancer Center. https://accamargo.org.br
  8. Fundação do Câncer (Brasil). https://www.cancer.org.br/
  9. Ministério da Saúde / BVS. ABC do câncer. https://bvsms.saude.gov.br/bvs/publicacoes/abc_do_cancer.pdf
  10. Instituto Nacional de Câncer (INCA). https://www.inca.gov.br/

Early public release. Content evolves through continuous review. Questions: [email protected] · CC BY 4.0 where applicable.